Prone positioning during extracorporeal membrane oxygenation in patients with severe ARDS: the PRONECMO randomized clinical trial

M Schmidt, D Hajage, G Lebreton, M Dres, C Guervilly… - JAMA, 2023 - jamanetwork.com
Importance Prone positioning may improve outcomes in patients with severe acute
respiratory distress syndrome (ARDS), but it is unknown whether prone positioning improves …

The history of extracorporeal membrane oxygenation and the development of extracorporeal membrane oxygenation anticoagulation

R Bartlett, DJ Arachichilage, M Chitlur… - … in Thrombosis and …, 2024 - thieme-connect.com
Extracorporeal membrane oxygenation (ECMO) was first started for humans in early 1970s
by Robert Bartlett. Since its inception, there have been numerous challenges with …

[HTML][HTML] Anticoagulation management during extracorporeal membrane oxygenation—A mini-review

F Burša, P Sklienka, M Frelich, O Jor, T Ekrtová, J Máca - Medicina, 2022 - mdpi.com
Extracorporeal membrane oxygenation (ECMO) has been established as a life-saving
technique for patients with the most severe forms of respiratory or cardiac failure. It can …

Anticoagulation and bleeding during veno-venous extracorporeal membrane oxygenation: insights from the PROTECMO study

G Martucci, M Giani, M Schmidt, K Tanaka… - American journal of …, 2024 - atsjournals.org
Rationale: Definitive guidelines for anticoagulation management during veno-venous
extracorporeal membrane oxygenation (VV ECMO) are lacking, whereas bleeding …

[HTML][HTML] Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a …

DJ Arachchillage, A Weatherill, I Rajakaruna… - Journal of Thrombosis …, 2023 - Elsevier
Background Bleeding and thrombosis are major complications of veno-venous (VV)
extracorporeal membrane oxygenation (ECMO). Objectives To assess thrombosis, major …

[PDF][PDF] Thrombosis, major bleeding, and survival in COVID-19 supported by VV-ECMO in the first vs second wave-multicentre observational study in the UK

DJ Arachchillage, A Weatherill, I Rajakaruna… - J Thromb …, 2023 - core.ac.uk
Background: Bleeding and thrombosis are major complications of veno-venous
extracorporeal membrane (VV-ECMO). Objectives: To assess thrombosis, major bleeding …

[HTML][HTML] Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

N Nesseler, A Mansour, M Schmidt, M Para, A Porto… - Critical Care, 2024 - Springer
Background Both critically ill patients with coronavirus disease 2019 (COVID-19) and
patients receiving extracorporeal membrane oxygenation (ECMO) support exhibit a high …

Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study

A Mansour, M Berahou, J Odot, A Pontis… - …, 2024 - pubs.asahq.org
Background Unfractionated heparin, administered during venoarterial extracorporeal
membrane oxygenation to prevent thromboembolic events, largely depends on plasma …

[HTML][HTML] Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane …

DA Hofmaenner, D Furfaro, LC Wild… - Intensive Care Medicine …, 2023 - Springer
Background Optimal anticoagulation strategies for COVID-19 patients with the acute
respiratory distress syndrome (ARDS) on venovenous extracorporeal membrane …

[HTML][HTML] ECMO in cardiogenic shock: time course of blood biomarkers and associated mortality

S Rajsic, R Breitkopf, UC Oezpeker, B Treml - Diagnostics, 2022 - mdpi.com
Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) is a
temporary life support for severe cardiogenic shock, gaining time for organ recovery …